CELU

SEC source: 0000899243-22-026184 · doc4.xml · nonDerivative · entry 1

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026188 · doc4.xml · derivative · entry 3

Fletcher Kyle · CIK 0001937742 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Class A Common Stock · 125,000 shares

Expires 2032-07-13

F3 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-026188 · doc4.xml · derivative · entry 2

Fletcher Kyle · CIK 0001937742 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,735

Underlying: Class A Common Stock · 6,735 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-026188 · doc4.xml · nonDerivative · entry 1

Fletcher Kyle · CIK 0001937742 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,432

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-026196 · doc4.xml · derivative · entry 2

Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,481

Underlying: Class A Common Stock · 38,481 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-026196 · doc4.xml · nonDerivative · entry 1

Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,810

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-026193 · doc4.xml · derivative · entry 2

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,152

Underlying: Class A Common Stock · 54,152 shares

Expires 2032-07-13

F2 · derivative.exercise_date: This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-026193 · doc4.xml · nonDerivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,145

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

SEC source: 0000899243-22-021123 · doc4.xml · derivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,413

Underlying: Class A Common Stock · 42,413 shares

Expires 2032-06-02

F1 · derivative.exercise_date: This option shall vest and become exercisable in three successive equal annual installments so that the option is vested in full on the three-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015901 · doc4.xml · derivative · entry 2

Jones Anne · CIK 0001869584 · Director · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,100

Underlying: Class A Common Stock · 48,100 shares

Expires 2032-04-13

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015901 · doc4.xml · nonDerivative · entry 1

Jones Anne · CIK 0001869584 · Director · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,405

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015908 · doc4.xml · derivative · entry 2

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,201

Underlying: Class A Common Stock · 96,201 shares

Expires 2032-04-13

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015908 · doc4.xml · nonDerivative · entry 1

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,809

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015906 · doc4.xml · derivative · entry 2

Beers David C · CIK 0001869583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,251

Underlying: Class A Common Stock · 120,251 shares

Expires 2032-04-13

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015906 · doc4.xml · nonDerivative · entry 1

Beers David C · CIK 0001869583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,011

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015912 · doc4.xml · derivative · entry 2

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 384,801

Underlying: Class A Common Stock · 384,801 shares

Expires 2032-04-13

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015912 · doc4.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,865,923

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015913 · doc4.xml · derivative · entry 2

Haines John R · CIK 0001867686 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,401

Underlying: Class A Common Stock · 192,401 shares

Expires 2032-04-13

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015913 · doc4.xml · nonDerivative · entry 1

Haines John R · CIK 0001867686 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,617

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015910 · doc4.xml · derivative · entry 2

Dunn Keary · CIK 0001868779 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,100

Underlying: Class A Common Stock · 48,100 shares

Expires 2032-04-13

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015910 · doc4.xml · nonDerivative · entry 1

Dunn Keary · CIK 0001868779 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,405

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015904 · doc4.xml · derivative · entry 2

Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,721

Underlying: Class A Common Stock · 57,721 shares

Expires 2032-04-13

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0000899243-22-015904 · doc4.xml · nonDerivative · entry 1

Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,686

F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0001567619-22-006998 · doc1.xml · derivative · entry 2

STARR INTERNATIONAL CO INC · CIK 0001236615 · 10% owner

Starr International Investments Ltd. · CIK 0001480100 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,640,694 shares

Expires not disclosed

F2 · derivative.expiration_date: The first to occur of: (a) March 16, 2025 or (b) the consummation of a Change of Control (as defined in the applicable warrant agreement) following March 1, 2022.

F1 · ownership.nature: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

SEC source: 0001567619-22-006998 · doc1.xml · nonDerivative · entry 1

STARR INTERNATIONAL CO INC · CIK 0001236615 · 10% owner

Starr International Investments Ltd. · CIK 0001480100 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,281,389

F1 · ownership.nature: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

SEC source: 0000899243-22-036454 · doc4.xml · nonDerivative · entry 1

Jones Anne · CIK 0001869584 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,888

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2 · balance_after: Represents 52,888 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-22-036452 · doc4.xml · nonDerivative · entry 2

Glover Bradley · CIK 0001867698 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,076

F3 · shares: Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under 2021 Plan and does not represent a sale.

F4 · balance_after: Includes 45,310 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-22-036452 · doc4.xml · nonDerivative · entry 1

Glover Bradley · CIK 0001867698 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,810

F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2 · balance_after: Represents 57,810 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

SEC source: 0000899243-21-046680 · doc4.xml · derivative · entry 2

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,437

Underlying: Class A Common Stock · 100,000 shares

Expires 2027-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0000899243-21-046680 · doc4.xml · nonDerivative · entry 1

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-21-048535 · ownership.xml · derivative · entry 1

Pecora Andrew L · CIK 0001510184 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,469,282

Underlying: Class A Common Stock · 2,469,282 shares

Expires 2031-09-15

F1 · derivative.exercise_date: This option shall vest and become exercisable in up to five installments in respect of achieving certain share price targets between the third and fourth anniversary of the effective date, September 15, 2021, subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0001213900-21-048290 · ownership.xml · derivative · entry 1

Mirakhur Beloo · CIK 0001883292 · EVP, Clinical Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Class A Common Stock · 125,000 shares

Expires 2031-09-13

F1 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, September 13, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and 1/48 of the total number of shares each month thereafter over the following three years, such that the options will be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer on each such date.

SEC source: 0001213900-21-047760 · ownership.xml · derivative · entry 1

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,718

Underlying: Class A Common Stock · 153,718 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0001213900-21-047746 · ownership.xml · derivative · entry 1

SCULLEY JOHN · CIK 0001015816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047738 · ownership.xml · derivative · entry 1

Beers David C · CIK 0001869583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,718

Underlying: Class A Common Stock · 153,718 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0001213900-21-047750 · ownership.xml · derivative · entry 1

Lim Kok Thay · CIK 0001470308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047740 · ownership.xml · derivative · entry 1

Kehler Dean C · CIK 0001322745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047742 · ownership.xml · derivative · entry 1

Bloom Jay R · CIK 0001322747 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047752 · ownership.xml · derivative · entry 1

Mazur Marc · CIK 0001361226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047758 · ownership.xml · derivative · entry 1

Smith Robin L · CIK 0001365035 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047756 · ownership.xml · derivative · entry 1

Hariri Robert J · CIK 0001398815 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,690,079

Underlying: Class A Common Stock · 2,690,079 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0001213900-21-047754 · ownership.xml · derivative · entry 1

Diamandis Peter · CIK 0001528288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047735 · ownership.xml · derivative · entry 1

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,053

Underlying: Class A Common Stock · 56,053 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.

SEC source: 0001213900-21-047748 · ownership.xml · derivative · entry 1

Dunn Keary · CIK 0001868779 · General Counsel & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,859

Underlying: Class A Common Stock · 76,859 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0001213900-21-047744 · ownership.xml · derivative · entry 1

Haines John R · CIK 0001867686 · Chief Ops & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 384,297

Underlying: Class A Common Stock · 384,297 shares

Expires 2031-09-09

F1 · derivative.exercise_date: This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date.

SEC source: 0001209191-21-046978 · doc4.xml · derivative · entry 4

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,859

Underlying: Class A Common Stock · 76,859 shares

Expires 2031-07-16

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001209191-21-046978 · doc4.xml · derivative · entry 3

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,846

Underlying: Class A Common Stock · 65,846 shares

Expires 2031-07-16

F2 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, August 30, 2019, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.

SEC source: 0001209191-21-046978 · doc4.xml · derivative · entry 2

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,872

Underlying: Class A Common Stock · 87,872 shares

Expires 2031-07-16

F2 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, August 30, 2019, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.

SEC source: 0001209191-21-046978 · doc4.xml · derivative · entry 1

Brigido Stephen · CIK 0001869791 · Pres, Functional Regeneration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,379

Underlying: Class A Common Stock · 20,379 shares

Expires 2031-07-16

F1 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, December 15, 2019, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.

SEC source: 0001209191-21-046979 · doc4.xml · derivative · entry 2

Dunn Keary · CIK 0001868779 · General Counsel & Business Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,089

Underlying: Class A Common Stock · 279,089 shares

Expires 2031-07-16

F1 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.